Ocrelizumab Discontinuation After Recurrent Serious Infections in Clinically Stable Primary Progressive Multiple Sclerosis: A Case Report
Study Overview Ocrelizumab is a monoclonal antibody that targets CD20-positive B cells and has been primarily utilized in the treatment […]

